These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 10644785)

  • 41. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR; Cornes CL
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.
    Raja M
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):145-51. PubMed ID: 7669821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L; Salazar Z; Micheli F
    Clin Neuropharmacol; 2009; 32(3):165-6. PubMed ID: 19483486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM; Davis KL; Berger PA
    J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of severe tardive dystonia and severe tardive dyskinesia.
    Yassa R; Nair V; Iskandar H
    Acta Psychiatr Scand; 1989 Aug; 80(2):155-9. PubMed ID: 2572146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphine in tardive and idiopathic dystonia (short communication).
    Berg D; Becker G; Naumann M; Reiners K
    J Neural Transm (Vienna); 2001; 108(8-9):1035-41. PubMed ID: 11716139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New-Onset Focal Task Specific Oromandibular Dystonia in Association with Quran Recitation: A Case Series.
    Al-Hashel JY; Soliman DY; Ismail II
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():3. PubMed ID: 38222897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
    Moscovich M; Chen ZP; Rodriguez R
    J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology.
    Yoshida K; Kaji R; Shibasaki H; Iizuka T
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):499-505. PubMed ID: 12418565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tardive dystonia.
    van Harten PN; Kahn RS
    Schizophr Bull; 1999; 25(4):741-8. PubMed ID: 10667744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Facial dyskinesias.
    Kaufman DM
    Psychosomatics; 1989; 30(3):263-9. PubMed ID: 2669010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tardive dyskinesia.
    Casey DE
    West J Med; 1990 Nov; 153(5):535-41. PubMed ID: 1979705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroleptic-induced tardive cervical dystonia: clinical series of 20 patients.
    Godeiro-Júnior C; Felício AC; Aguiar PC; Borges V; Silva SM; Ferraz HB
    Can J Neurol Sci; 2009 Mar; 36(2):222-6. PubMed ID: 19378719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral and genital tardive pain syndromes.
    Ford B; Greene P; Fahn S
    Neurology; 1994 Nov; 44(11):2115-9. PubMed ID: 7969969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin in a case of severe tardive dyskinesia mixed with dystonia.
    Stip E; Faughnan M; Desjardin I; Labrecque R
    Br J Psychiatry; 1992 Dec; 161():867-8. PubMed ID: 1362371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.